Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | TNKS | O95271 | 1/20 | 0.35 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | PDE1A | P54750 | 1/20 | 0.33 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.33 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21066142 | 0.78 | CA1 (0.51) | KDM4EGAAALDH1A1MAPTHPGD | |
| SCHEMBL22839966 | 0.74 | ALDH1A1 (0.45) | POLBALDH1A1HPGD | |
| SCHEMBL21066088 | 0.73 | CA1 (0.46) | — | |
| SCHEMBL10389700 | 0.73 | POLB (0.64) | POLBALDH1A1MAPTHPGD | |
| SCHEMBL21066144 | 0.72 | CA1 (0.40) | GAAALDH1A1MAPTHPGD | |
| SCHEMBL22840044 | 0.72 | MAOB (0.43) | — | |
| SCHEMBL7376416 | 0.70 | MIF (0.57) | GAAMAPT | |
| SCHEMBL21066133 | 0.69 | CA12 (0.41) | KDM4ETNKSTNKS2NISCHPOLB | |
| SCHEMBL20182358 | 0.68 | CA1 (0.35) | POLBALDH1A1MAPTHPGD | |
| SCHEMBL21066085 | 0.67 | LMNA (0.45) | GAAPOLBALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3497101-B1 | SUBSTITUTED 2-HETEROCYCLYL IMIDAZOLYL-CARBOXAMIDES AS PESTICIDES | BAYER CROPSCIENCE AG (DE) | 2020-12-30 | — | — | EP | disclosed |
| US-10660333-B2 | Substituted 2-heterocyclylimidazolylcarboxamides as pesticides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2020-05-26 | — | — | US | disclosed |
| US-20190166837-A1 | SUBSTITUTED 2-HETEROCYCLYLIMIDAZOLYLCARBOXAMIDES AS PESTICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2019-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190166837-A1 | SUBSTITUTED 2-HETEROCYCLYLIMIDAZOLYLCARBOXAMIDES AS PESTICIDES | DDT, PTMS, TSNAX | KDM4E 340/4885GAA 1228/4885TNKS 2657/4885 |
| US-10660333-B2 | Substituted 2-heterocyclylimidazolylcarboxamides as pesticides | DDT, PTMS, TSNAX | KDM4E 340/4885GAA 1228/4885TNKS 2657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.